Article Text

CLINICAL TRAIL OF IV ETOPOSIDE, CARBOPLATIN AND CYCLOPHOSPHAMIDE COMBINATION CHEMOTHERAPY AGAINST PERSISTENT OR RECURRENT OVARIAN CANCER AS 2ND OR MORE LINE CHEMOTHERAPY

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.